{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:54:48Z","timestamp":1793145288425,"version":"4.5.0"},"reference-count":225,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation Project of Xinjiang Uygur Autonomous Region","award":["2024D01C266"],"award-info":[{"award-number":["2024D01C266"]}]},{"name":"Xinjiang Uygur Autonomous Region Tianchi Talent Introduction Program-Young Doctor","award":["5105250184p"],"award-info":[{"award-number":["5105250184p"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471260"],"award-info":[{"award-number":["32471260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Colon cancer (CC) remains a leading cause of cancer-related mortality worldwide, with multidrug resistance (MDR) presenting a formidable barrier to successful chemotherapy. Ferroptosis\u2014an iron-dependent, lipid peroxidation-driven form of cell death\u2014offers a novel therapeutic avenue to bypass MDR by exploiting metabolic vulnerabilities distinct from traditional apoptosis pathways. Emerging evidence reveals a dynamic interplay between MDR and ferroptosis: MDR cancer cells suppress ferroptosis through NRF2\/GPX4-mediated antioxidant upregulation, iron sequestration by ferritin, and lipid metabolism reprogramming, including SREBP1-driven monounsaturated fatty acid accumulation, while ABC transporters actively efflux ferroptosis inducers. On the other hand, ferroptosis inducers such as erastin and RSL3 have the potential to overcome apoptotic resistance and avoid efflux pathways, which recover therapeutic efficacy. This review first describes the primary mechanisms of chemotherapy resistance in colon cancer and then explains the molecular processes that prevent ferroptosis in resistant cells. We also review recent data on the complex interactions between resistance to chemotherapy and ferroptosis, and outline approaches that may stimulate iron accumulation to reverse MDR. By emphasizing novel methods to induce ferroptosis, this review highlights that this approach is a promising strategy to overcome chemotherapy resistance in colon cancer and will facilitate the development of more precise and efficient treatment.<\/jats:p>","DOI":"10.3390\/ph19020252","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:00:47Z","timestamp":1770033647000},"page":"252","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Ferroptosis as a Novel Therapeutic Strategy to Overcome Multidrug Resistance in Colorectal Cancer"],"prefix":"10.3390","volume":"19","author":[{"given":"Dina","family":"Mahemuti","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Science, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfei","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Siddiqe","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Tang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Kong","sequence":"additional","affiliation":[{"name":"College of Smart Agriculture, Xinjiang University, Urumqi 830046, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-4277","authenticated-orcid":false,"given":"Wenfang","family":"Li","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3558-001X","authenticated-orcid":false,"given":"Zhengding","family":"Su","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4363-7642","authenticated-orcid":false,"given":"Ayitila","family":"Maimaitijiang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science, Institute of Materia Medica, College of Life Science and Technology, Xinjiang University, Urumqi 830017, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2025, August 25). Colorectal Cancer. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/colorectal-cancer."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(24)00360-X","article-title":"Colorectal cancer","volume":"404","author":"Eng","year":"2024","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.biopha.2014.10.019","article-title":"Colon cancer: Cancer stem cells markers, drug resistance and treatment","volume":"68","author":"Kozovska","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.7150\/thno.44705","article-title":"Combinative treatment of \u03b2-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lorenzato, A., Magr\u00ec, A., Matafora, V., Audrito, V., Arcella, P., Lazzari, L., Montone, M., Lamba, S., Deaglio, S., and Siena, S. (2020). Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer. Cancers, 12.","DOI":"10.3390\/cancers12030685"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1038\/s41467-019-11530-0","article-title":"Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients","volume":"10","author":"Serebriiskii","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Bukowski, K., Kciuk, M., and Kontek, R. (2020). Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093233"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches","volume":"347","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drup.2012.01.005","article-title":"Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance","volume":"15","author":"Shukla","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"114542","DOI":"10.1016\/j.ejmech.2022.114542","article-title":"Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update","volume":"239","author":"Engle","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: Role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nsmb.3216","article-title":"Mechanistic diversity in ATP-binding cassette (ABC) transporters","volume":"23","author":"Locher","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-biophys-111622-091232","article-title":"Structure and Mechanism of Human ABC Transporters","volume":"52","author":"Alam","year":"2023","journal-title":"Annu. Rev. Biophys."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","article-title":"Human ATP-binding cassette (ABC) transporter family","volume":"3","author":"Vasiliou","year":"2009","journal-title":"Hum. Genom."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e11171","DOI":"10.1016\/j.heliyon.2022.e11171","article-title":"P-glycoprotein and cancer: What do we currently know?","volume":"8","author":"Heming","year":"2022","journal-title":"Heliyon"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1476-5381.2011.01649_1.x","article-title":"Guide to Receptors and Channels (GRAC), 5th edition","volume":"164","author":"Alexander","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"30880","DOI":"10.1074\/jbc.R114.609248","article-title":"Multidrug resistance protein 1 (MRP1, ABCC1), a \u201cmultitasking\u201d ATP-binding cassette (ABC) transporter","volume":"289","author":"Cole","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1042\/BST20150139","article-title":"ABC transporter research: Going strong 40 years on","volume":"43","author":"Theodoulou","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138920111795164075","article-title":"Regulation of ABC transporter function via phosphorylation by protein kinases","volume":"12","author":"Stolarczyk","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_21","first-page":"235","article-title":"ATP-binding cassette (ABC) transporters in human metabolism and diseases","volume":"53","author":"Poledne","year":"2004","journal-title":"Physiol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"114346","DOI":"10.1016\/j.ejmech.2022.114346","article-title":"Targeting breast cancer resistance protein (BCRP\/ABCG2): Functional inhibitors and expression modulators","volume":"237","author":"Zattoni","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1126\/science.aar7389","article-title":"Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation","volume":"359","author":"Kim","year":"2018","journal-title":"Science"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nm.3174","article-title":"Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions","volume":"19","author":"Wang","year":"2013","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"41376","DOI":"10.1038\/srep41376","article-title":"Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein","volume":"7","author":"Telbisz","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pharmtox-011613-135959","article-title":"Targeting multidrug resistance protein 1 (MRP1, ABCC1): Past, present, and future","volume":"54","author":"Cole","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"10597","DOI":"10.7314\/APJCP.2014.15.24.10597","article-title":"RNAi-based knockdown of multidrug resistance-associated protein 1 is sufficient to reverse multidrug resistance of human lung cells","volume":"15","author":"Shao","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2147\/OTT.S82835","article-title":"Hypoxia-inducible factor-1\u03b1 induces multidrug resistance protein in colon cancer","volume":"8","author":"Lv","year":"2015","journal-title":"Onco Targets Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-017-0657-0","article-title":"PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy","volume":"16","author":"Salaroglio","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1470-2045(00)00032-2","article-title":"Effect of the breast-cancer resistance protein on atypical multidrug resistance","volume":"1","author":"Lage","year":"2000","journal-title":"Lancet Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ronaldson, P.T., and Davis, T.P. (2022). Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14071501"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gote, V., Nookala, A.R., Bolla, P.K., and Pal, D. (2021). Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094673"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Bo, L., Wang, Y., Li, Y., Wurpel, J.N.D., Huang, Z., and Chen, Z.S. (2023). The Battlefield of Chemotherapy in Pediatric Cancers. Cancers, 15.","DOI":"10.3390\/cancers15071963"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Pardridge, W.M. (2022). Advanced Blood-Brain Barrier Drug Delivery. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010093"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves, B.M.F., Cardoso, D.S.P., and Ferreira, M.-J.U. (2020). Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators. Molecules, 25.","DOI":"10.3390\/molecules25153364"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/138161210790112674","article-title":"Pharmacogenetics of phase I and phase II drug metabolism","volume":"16","author":"Crettol","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Mahinfar, P., Mansoori, B., Rostamzadeh, D., Baradaran, B., Cho, W.C., and Mansoori, B. (2022). The Role of microRNAs in Multidrug Resistance of Glioblastoma. Cancers, 14.","DOI":"10.3390\/cancers14133217"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tox.2012.06.013","article-title":"Evidence for nevirapine bioactivation in man: Searching for the first step in the mechanism of nevirapine toxicity","volume":"301","author":"Caixas","year":"2012","journal-title":"Toxicology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Xue, Z., Chen, Z., Wang, Y., and Sun, W. (2023). Proteomic Analysis Reveals the Association between the Pathways of Glutathione and \u03b1-Linolenic Acid Metabolism and Lanthanum Accumulation in Tea Plants. Molecules, 28.","DOI":"10.3390\/molecules28031124"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbadis.2011.01.014","article-title":"Nuclear receptor PXR, transcriptional circuits and metabolic relevance","volume":"1812","author":"Ihunnah","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.lfs.2010.09.012","article-title":"Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals","volume":"88","author":"Pal","year":"2011","journal-title":"Life Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1038\/s41467-019-12073-0","article-title":"GSTA4 mediates reduction of cisplatin ototoxicity in female mice","volume":"10","author":"Park","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10409239509083491","article-title":"The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance","volume":"30","author":"Hayes","year":"1995","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"122720","DOI":"10.1016\/j.lfs.2024.122720","article-title":"Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance","volume":"349","author":"Kapper","year":"2024","journal-title":"Life Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e00595-17","DOI":"10.1128\/mBio.00595-17","article-title":"Mismatch Repair of DNA Replication Errors Contributes to Microevolution in the Pathogenic Fungus Cryptococcus neoformans","volume":"8","author":"Boyce","year":"2017","journal-title":"mBio"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00384-021-04046-x","article-title":"Systematic review and meta-analysis of tumour microsatellite-instability status as a predictor of response to fluorouracil-based adjuvant chemotherapy in colorectal cancer","volume":"37","author":"Aggarwal","year":"2022","journal-title":"Int. J. Color. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1093\/nar\/gkae102","article-title":"Novel insights into the role of translesion synthesis polymerase in DNA incorporation and bypass of 5-fluorouracil in colorectal cancer","volume":"52","author":"Averill","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gki173","article-title":"APE1 overexpression in XRCC1-deficient cells complements the defective repair of oxidative single strand breaks but increases genomic instability","volume":"33","author":"Sossou","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li, H., Wang, C., Lan, L., Wu, W., Evans, I., Ruiz, E.J., Yan, L., Zhou, Z., Oliveira, J.M., and Reis, R.L. (2021). PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.719192"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"44068","DOI":"10.1074\/jbc.M306160200","article-title":"Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1","volume":"278","author":"Marsin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ygyno.2012.03.006","article-title":"BRCA1\/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer","volume":"125","author":"Dann","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.7150\/jca.65650","article-title":"Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients","volume":"13","author":"Zong","year":"2022","journal-title":"J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13046-022-02265-w","article-title":"Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients","volume":"41","author":"Buttarelli","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Zhu, S., Zhu, Y., Wang, Q., Zhang, Y., and Guo, X. (2021). CHK Methylation Is Elevated in Colon Cancer Cells and Contributes to the Oncogenic Properties. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.708038"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1073\/pnas.95.15.8698","article-title":"Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers","volume":"95","author":"Veigl","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1097-0215(19991029)83:3<309::AID-IJC4>3.0.CO;2-Z","article-title":"Distinct methylation pattern and microsatellite instability in sporadic gastric cancer","volume":"83","author":"Suzuki","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tins.2009.06.002","article-title":"Multiple roles of HDAC inhibition in neurodegenerative conditions","volume":"32","author":"Chuang","year":"2009","journal-title":"Trends Neurosci."},{"key":"ref_63","first-page":"1305","article-title":"Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer","volume":"52","author":"He","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Yoon, S., Kang, G., and Eom, G.H. (2019). HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20061329"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"De Angelis, M.L., Francescangeli, F., La Torre, F., and Zeuner, A. (2019). Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00626"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Anastasiadou, E., Faggioni, A., Trivedi, P., and Slack, F.J. (2018). The Nefarious Nexus of Noncoding RNAs in Cancer. Int. J. Mol. Sci., 19.","DOI":"10.20944\/preprints201803.0187.v1"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"81572","DOI":"10.18632\/oncotarget.19197","article-title":"The role of miRNA and lncRNA in gastric cancer","volume":"8","author":"Hao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1093\/nar\/gks776","article-title":"Genome-wide analysis reveals distinct patterns of epigenetic features in long non-coding RNA loci","volume":"40","author":"Sati","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.csbj.2022.04.015","article-title":"Noncoding RNAs endogenously rule the cancerous regulatory realm while proteins govern the normal","volume":"20","author":"Wang","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/092986712800167392","article-title":"Three decades of P-gp inhibitors: Skimming through several generations and scaffolds","volume":"19","author":"Palmeira","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3109\/14756366.2016.1149476","article-title":"Advances in plant-based inhibitors of P-glycoprotein","volume":"31","author":"Yu","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"100681","DOI":"10.1016\/j.drup.2020.100681","article-title":"Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update","volume":"49","author":"Dong","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bcp.2015.12.007","article-title":"Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein","volume":"101","author":"Chufan","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/med.20239","article-title":"Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression","volume":"32","author":"Nobili","year":"2012","journal-title":"Med. Res. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1158\/1078-0432.CCR-10-1725","article-title":"A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer","volume":"17","author":"Kelly","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejmech.2017.06.047","article-title":"Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer","volume":"138","author":"Joshi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nano.2013.08.009","article-title":"Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein","volume":"10","author":"Wang","year":"2014","journal-title":"Nanomedicine"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s40824-023-00465-9","article-title":"A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs","volume":"27","author":"Lv","year":"2023","journal-title":"Biomater. Res."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Vanti, G., Coronnello, M., Bani, D., Mannini, A., Bergonzi, M.C., and Bilia, A.R. (2021). Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030306"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/1476-4598-9-305","article-title":"Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation","volume":"9","author":"Gravina","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41575-019-0230-y","article-title":"Epigenetics of colorectal cancer: Biomarker and therapeutic potential","volume":"17","author":"Jung","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3324\/haematol.2017.177279","article-title":"Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas","volume":"103","author":"Kitadate","year":"2018","journal-title":"Haematologica"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3892\/ijo.2014.2550","article-title":"Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells","volume":"45","author":"Coersmeyer","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3892\/ijo.2012.1707","article-title":"MiR-21 regulates biological behavior through the PTEN\/PI-3 K\/Akt signaling pathway in human colorectal cancer cells","volume":"42","author":"Xiong","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Cao, Q., Wu, X., Zhang, Q., Gong, J., Chen, Y., You, Y., Shen, J., Qiang, Y., and Cao, G. (2023). Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: A literature review. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1291920"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1038\/s41418-021-00816-w","article-title":"BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer","volume":"28","author":"Ramesh","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., and Wang, J. (2022). The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.985363"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2010.10.009","article-title":"Targeting c-FLIP in cancer","volume":"332","author":"Shirley","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Alimbetov, D., Askarova, S., Umbayev, B., Davis, T., and Kipling, D. (2018). Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061690"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1158\/1535-7163.MCT-05-0262","article-title":"Chemotherapy and TRAIL-mediated colon cancer cell death: The roles of p53, TRAIL receptors, and c-FLIP","volume":"4","author":"Galligan","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3892\/ijmm.2015.2126","article-title":"miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K\/Akt\/mTOR signaling pathway","volume":"35","author":"Zhang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2147\/OTT.S224465","article-title":"Self-Renewal Signalling Pathway Inhibitors: Perspectives on Therapeutic Approaches for Cancer Stem Cells","volume":"13","author":"Zhu","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41598-017-18421-8","article-title":"Beta-catenin cleavage enhances transcriptional activation","volume":"8","author":"Goretsky","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","article-title":"The development of the concept of ferroptosis","volume":"133","author":"Hirschhorn","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Liu, J., Zhang, C., Wang, J., Hu, W., and Feng, Z. (2020). The Regulation of Ferroptosis by Tumor Suppressor p53 and its Pathway. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218387"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Zhang, G., Lv, S., Zhong, X., Li, X., Yi, Y., Lu, Y., Yan, W., Li, J., and Teng, J. (2023). Ferroptosis: A new antidepressant pharmacological mechanism. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1339057"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Chen, X., Comish, P.B., Tang, D., and Kang, R. (2021). Characteristics and Biomarkers of Ferroptosis. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.637162"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-022-02570-3","article-title":"Ferroptosis is involved in regulating perioperative neurocognitive disorders: Emerging perspectives","volume":"19","author":"Song","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Xia, Y., Wang, F., Yang, D., and Liang, Z. (2024). Induction of ferroptosis by natural products in non-small cell lung cancer: A comprehensive systematic review. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1385565"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Battaglia, A.M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F., and Biamonte, F. (2020). Ferroptosis and Cancer: Mitochondria Meet the \u201cIron Maiden\u201d Cell Death. Cells, 9.","DOI":"10.3390\/cells9061505"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Lesjak, M., Simin, N., and Srai, S.K.S. (2022). Can Polyphenols Inhibit Ferroptosis?. Antioxidants, 11.","DOI":"10.3390\/antiox11010150"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: Past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Reichert, C.O., de Freitas, F.A., Sampaio-Silva, J., Rokita-Rosa, L., Barros, P.L., Levy, D., and Bydlowski, S.P. (2020). Ferroptosis Mechanisms Involved in Neurodegenerative Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228765"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Lei, X.L., Zhao, G.Y., Guo, R., and Cui, N. (2022). Ferroptosis in sepsis: The mechanism, the role and the therapeutic potential. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.956361"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41416-022-01998-x","article-title":"Ferroptosis in hepatocellular carcinoma: Mechanisms and targeted therapy","volume":"128","author":"Ajoolabady","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"108046","DOI":"10.1016\/j.biotechadv.2022.108046","article-title":"Bacterial lipoxygenases: Biochemical characteristics, molecular structure and potential applications","volume":"61","author":"Chrisnasari","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Rochette, L., Dogon, G., Rigal, E., Zeller, M., Cottin, Y., and Vergely, C. (2022). Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010449"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","article-title":"GPX4 in cell death, autophagy, and disease","volume":"19","author":"Xie","year":"2023","journal-title":"Autophagy"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Tang, Y., Zhuang, Y., Zhao, C., Gu, S., Zhang, J., Bi, S., Wang, M., Bao, L., Li, M., and Zhang, W. (2024). The metabolites from traditional Chinese medicine targeting ferroptosis for cancer therapy. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1280779"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41420-021-00660-4","article-title":"Ferroptosis in liver disease: New insights into disease mechanisms","volume":"7","author":"Wu","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.2147\/OTT.S254995","article-title":"The Role of Erastin in Ferroptosis and Its Prospects in Cancer Therapy","volume":"13","author":"Zhao","year":"2020","journal-title":"Onco Targets Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41420-023-01431-z","article-title":"Correction: Recent progress in ferroptosis: Inducers and inhibitors","volume":"9","author":"Du","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/med.21933","article-title":"Ferroptosis-modulating small molecules for targeting drug-resistant cancer: Challenges and opportunities in manipulating redox signaling","volume":"43","author":"Koeberle","year":"2023","journal-title":"Med. Res. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Silva, A.M.N., and Rangel, M. (2022). The (Bio)Chemistry of Non-Transferrin-Bound Iron. Molecules, 27.","DOI":"10.3390\/molecules27061784"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/B:NEON.0000024238.21349.37","article-title":"Desferoxamine (DFO)\u2014Mediated iron chelation: Rationale for a novel approach to therapy for brain cancer","volume":"67","author":"Dayani","year":"2004","journal-title":"J. Neurooncol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Eltayeb, K., La Monica, S., Tiseo, M., Alfieri, R., and Fumarola, C. (2022). Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer. Cells, 11.","DOI":"10.3390\/cells11030413"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41419-023-05787-z","article-title":"Molecular characterization of AIFM2\/FSP1 inhibition by iFSP1-like molecules","volume":"14","author":"Schulte","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1038\/s41375-019-0461-5","article-title":"The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies","volume":"33","author":"Christian","year":"2019","journal-title":"Leukemia"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","article-title":"The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Kong, J., Lyu, H., Ouyang, Q., Shi, H., Zhang, R., Xiao, S., Guo, D., Zhang, Q., Chen, X.Z., and Zhou, C. (2024). Insights into the Roles of Epigenetic Modifications in Ferroptosis. Biology, 13.","DOI":"10.3390\/biology13020122"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1038\/s41467-021-25632-1","article-title":"Gene interfered-ferroptosis therapy for cancers","volume":"12","author":"Gao","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10565-024-09907-z","article-title":"Let\u2019s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment","volume":"40","author":"Bayat","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2018.05.074","article-title":"The tumor suppressor protein p53 and the ferroptosis network","volume":"133","author":"Kang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","article-title":"Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses","volume":"113","author":"Ou","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","article-title":"FSP1: A key regulator of ferroptosis","volume":"29","author":"Li","year":"2023","journal-title":"Trends Mol. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: An essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin. Med. J. Engl."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","article-title":"NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis","volume":"23","author":"Dodson","year":"2019","journal-title":"Redox Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e16239","DOI":"10.7717\/peerj.16239","article-title":"A review on the relationship between Arachidonic acid 15-Lipoxygenase (ALOX15) and diabetes mellitus","volume":"11","author":"He","year":"2023","journal-title":"PeerJ"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"468","DOI":"10.20517\/cdr.2023.29","article-title":"The multidrug resistance transporter P-glycoprotein confers resistance to ferroptosis inducers","volume":"6","author":"Frye","year":"2023","journal-title":"Cancer Drug Resist."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ctrv.2015.03.005","article-title":"Variability in bioavailability of small molecular tyrosine kinase inhibitors","volume":"41","author":"Herbrink","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Li, F.J., Long, H.Z., Zhou, Z.W., Luo, H.Y., Xu, S.G., and Gao, L.C. (2022). System X(c) (-)\/GSH\/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.910292"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Mirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Azami, N., Hamzehlou, S., Farahani, M.V., Hushmandi, K., and Ashrafizadeh, M. (2021). Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery. Antioxidants, 10.","DOI":"10.3390\/antiox10030349"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Mac\u00edas-Rodr\u00edguez, R.U., Inzaugarat, M.E., Ruiz-Marg\u00e1in, A., Nelson, L.J., Trautwein, C., and Cubero, F.J. (2020). Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis-A Novel Form of Non-Apoptotic Cell Death?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051651"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents","volume":"32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"8379","DOI":"10.1007\/s00432-023-04734-x","article-title":"The role of the Nrf2\/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours","volume":"149","author":"Zisterer","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12935-021-01822-1","article-title":"Targeting Nrf2 may reverse the drug resistance in ovarian cancer","volume":"21","author":"Li","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1038\/onc.2017.11","article-title":"Iron addiction: A novel therapeutic target in ovarian cancer","volume":"36","author":"Basuli","year":"2017","journal-title":"Oncogene"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"7053451","DOI":"10.1155\/2016\/7053451","article-title":"Long-Term Alteration of Reactive Oxygen Species Led to Multidrug Resistance in MCF-7 Cells","volume":"2016","author":"Cen","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Tolmacheva, I., Beloglazova, Y., Nazarov, M., Gagarskikh, O., and Grishko, V. (2023). Synthesis and Anticancer Activity of A-Ring-Modified Derivatives of Dihydrobetulin. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24129863"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e0015122","DOI":"10.1128\/aac.00151-22","article-title":"Deletion of cox7c Results in Pan-Azole Resistance in Aspergillus fumigatus","volume":"66","author":"Chen","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Menon, A.V., and Kim, J. (2022). Iron Promotes Cardiac Doxorubicin Retention and Toxicity Through Downregulation of the Mitochondrial Exporter ABCB8. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.817951"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"19530","DOI":"10.1074\/jbc.271.32.19530","article-title":"Accumulation of glucosylceramides in multidrug-resistant cancer cells","volume":"271","author":"Lavie","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1186\/s12951-024-02842-5","article-title":"Nanobiotechnology boosts ferroptosis: Opportunities and challenges","volume":"22","author":"Han","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","article-title":"Ferroptosis: Principles and significance in health and disease","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e02523","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"eLife"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Huang, C.Y., Chen, L.J., Chen, G., Chao, T.I., and Wang, C.Y. (2022). SHP-1\/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911092"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Grignano, E., Birsen, R., Chapuis, N., and Bouscary, D. (2020). From Iron Chelation to Overload as a Therapeutic Strategy to Induce Ferroptosis in Leukemic Cells. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.586530"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Brown, R.A.M., Richardson, K.L., Kabir, T.D., Trinder, D., Ganss, R., and Leedman, P.J. (2020). Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00476"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Weaver, K., and Skouta, R. (2022). The Selenoprotein Glutathione Peroxidase 4: From Molecular Mechanisms to Novel Therapeutic Opportunities. Biomedicines, 10.","DOI":"10.20944\/preprints202202.0316.v1"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Bai, Q., Liu, J., and Wang, G. (2020). Ferroptosis, a Regulated Neuronal Cell Death Type After Intracerebral Hemorrhage. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.591874"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41419-022-04927-1","article-title":"Regulatory pathways and drugs associated with ferroptosis in tumors","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1089\/ars.2017.7176","article-title":"The Roles of NRF2 in Modulating Cellular Iron Homeostasis","volume":"29","author":"Kerins","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"ref_158","first-page":"323","article-title":"Erastin\/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2\/xCT pathway","volume":"19","author":"Li","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Cheng, H., Wang, P., Wang, N., Dong, W., Chen, Z., Wu, M., Wang, Z., Yu, Z., Guan, D., and Wang, L. (2023). Neuroprotection of NRF2 against Ferroptosis after Traumatic Brain Injury in Mice. Antioxidants, 12.","DOI":"10.3390\/antiox12030731"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Qu, H., Chen, Y., Luo, X., Chen, C., Xiao, B., Ding, X., Zhao, P., Lu, Y., and Chen, A.F. (2022). Atorvastatin Induces Mitochondria-Dependent Ferroptosis via the Modulation of Nrf2-xCT\/GPx4 Axis. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.806081"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Scalise, M., Console, L., Rovella, F., Galluccio, M., Pochini, L., and Indiveri, C. (2020). Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring. Cells, 9.","DOI":"10.3390\/cells9092028"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"570","DOI":"10.37349\/etat.2022.00101","article-title":"A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options","volume":"3","author":"Criscuolo","year":"2022","journal-title":"Explor. Target. Antitumor Ther."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Lee, N., Carlisle, A.E., Peppers, A., Park, S.J., Doshi, M.B., Spears, M.E., and Kim, D. (2021). xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers. Antioxidants, 10.","DOI":"10.3390\/antiox10020317"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","article-title":"The ferroptosis inducer erastin irreversibly inhibits system x(c)- and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells","volume":"8","author":"Sato","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41422-022-00642-w","article-title":"The structure of erastin-bound xCT-4F2hc complex reveals molecular mechanisms underlying erastin-induced ferroptosis","volume":"32","author":"Yan","year":"2022","journal-title":"Cell Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e2207693","DOI":"10.1002\/advs.202207693","article-title":"Transferrin Receptor-Mediated Iron Uptake Promotes Colon Tumorigenesis","volume":"10","author":"Kim","year":"2023","journal-title":"Adv. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Zhuang, C., Li, X., Yang, L., Ma, X., Shen, Y., Huang, C., Pan, T., Cui, J., Ni, B., and Wang, M. (2023). Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1151687"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"273","DOI":"10.17219\/acem\/168342","article-title":"Transferrin receptor modulated by microRNA-497-5p suppresses cervical cancer cell malignant phenotypes","volume":"33","author":"Fang","year":"2024","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.2147\/JIR.S389290","article-title":"Ferroptosis: Reviewing CRC with the Third Eye","volume":"15","author":"Liu","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"630","DOI":"10.20892\/j.issn.2095-3941.2019.0158","article-title":"The crosstalk between autophagy and ferroptosis: What can we learn to target drug resistance in cancer?","volume":"16","author":"Zhou","year":"2019","journal-title":"Cancer Biol. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1586\/17474086.2016.1124757","article-title":"Modulation of hepcidin to treat iron deregulation: Potential clinical applications","volume":"9","author":"Blanchette","year":"2016","journal-title":"Expert Rev. Hematol."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Hawula, Z.J., Wallace, D.F., Subramaniam, V.N., and Rishi, G. (2019). Therapeutic Advances in Regulating the Hepcidin\/Ferroportin Axis. Pharmaceuticals, 12.","DOI":"10.3390\/ph12040170"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Yang, Y., Zhu, T., Wang, X., Xiong, F., Hu, Z., Qiao, X., Yuan, X., and Wang, D. (2022). ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers. Cancers, 14.","DOI":"10.3390\/cancers14235896"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"42632","DOI":"10.18632\/oncotarget.5822","article-title":"Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer","volume":"6","author":"Orlando","year":"2015","journal-title":"Oncotarget"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","article-title":"Resolving the Role of Lipoxygenases in the Initiation and Execution of Ferroptosis","volume":"4","author":"Shah","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/cas.13380","article-title":"Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3","volume":"108","author":"Shintoku","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Yan, R., Lin, B., Jin, W., Tang, L., Hu, S., and Cai, R. (2023). NRF2, a Superstar of Ferroptosis. Antioxidants, 12.","DOI":"10.20944\/preprints202308.1554.v1"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"a004754","DOI":"10.1101\/cshperspect.a004754","article-title":"Regulation of cholesterol and fatty acid synthesis","volume":"3","author":"Ye","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tibs.2018.01.005","article-title":"SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond","volume":"43","author":"Ye","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Zhao, Q., Lin, X., and Wang, G. (2022). Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.952371"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: A Novel Anti-tumor Action for Cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Claudio-Ares, O., Luciano-Rodr\u00edguez, J., Del Valle-Gonz\u00e1lez, Y.L., Schiavone-Chamorro, S.L., Pastor, A.J., Rivera-Reyes, J.O., Metzler, C.L., Dom\u00ednguez-Orona, L.M., Vargas-P\u00e9rez, B.L., and Skouta, R. (2024). Exploring the Use of Intracellular Chelation and Non-Iron Metals to Program Ferroptosis for Anticancer Application. Inorganics, 12.","DOI":"10.3390\/inorganics12010026"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jconrel.2020.01.012","article-title":"Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo","volume":"319","author":"Wei","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_187","first-page":"4631","article-title":"Immobilized transferrin Fe3O4@SiO2 nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery","volume":"8","author":"Ding","year":"2013","journal-title":"Int. J. Nanomed."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: A novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"786","DOI":"10.21037\/tlcr-22-318","article-title":"Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance","volume":"11","author":"Zhang","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40364-020-00229-w","article-title":"Novel insights on targeting ferroptosis in cancer therapy","volume":"8","author":"Zuo","year":"2020","journal-title":"Biomark. Res."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Wang, H., Lin, D., Yu, Q., Li, Z., Lenahan, C., Dong, Y., Wei, Q., and Shao, A. (2021). A Promising Future of Ferroptosis in Tumor Therapy. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.629150"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: Present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cac2.12487","article-title":"The crosstalk between ferroptosis and anti-tumor immunity in the tumor microenvironment: Molecular mechanisms and therapeutic controversy","volume":"43","author":"Zheng","year":"2023","journal-title":"Cancer Commun."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"DeRosa, A., and Leftin, A. (2021). The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.614294"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"21494","DOI":"10.1021\/acsomega.4c02116","article-title":"ADME\/PK Insights of Crocetin: A Molecule Having an Unusual Chemical Structure with Druglike Features","volume":"9","author":"Manhas","year":"2024","journal-title":"ACS Omega"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1039\/C6MD00500D","article-title":"Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: A novel approach to activate Nrf2 function","volume":"8","author":"Zhuang","year":"2017","journal-title":"Medchemcomm"},{"key":"ref_200","first-page":"247597","article-title":"Antitumor activity of artemisinin and its derivatives: From a well-known antimalarial agent to a potential anticancer drug","volume":"2012","author":"Wei","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1745-7254.2006.00238.x","article-title":"Flavonoid-membrane interactions: Possible consequences for biological effects of some polyphenolic compounds","volume":"27","author":"Hendrich","year":"2006","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"e000527","DOI":"10.1136\/jitc-2020-000527","article-title":"Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression","volume":"8","author":"Costantini","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"16436","DOI":"10.1038\/s41598-021-95985-6","article-title":"Liquid biopsy uncovers distinct patterns of DNA methylation and copy number changes in NSCLC patients with different EGFR-TKI resistant mutations","volume":"11","author":"Nguyen","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Steifensand, F., Gallwas, J., Bauerschmitz, G., and Gr\u00fcndker, C. (2021). Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells. Cells, 10.","DOI":"10.3390\/cells10092398"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"24506","DOI":"10.18632\/oncotarget.15534","article-title":"Pirfenidone normalizes the tumor microenvironment to improve chemotherapy","volume":"8","author":"Polydorou","year":"2017","journal-title":"Oncotarget"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Chen, J., Ding, Z., Peng, Y., Pan, F., Li, J., Zou, L., Zhang, Y., and Liang, H. (2014). HIF-1\u03b1 inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1\/P-glycoprotein. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098882"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/bcr432","article-title":"Liposome-based drug delivery in breast cancer treatment","volume":"4","author":"Park","year":"2002","journal-title":"Breast Cancer Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/IJN.S158696","article-title":"Stimuli-responsive polymeric micelles for drug delivery and cancer therapy","volume":"13","author":"Zhou","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"btad645","DOI":"10.1093\/bioinformatics\/btad645","article-title":"DELFOS-drug efficacy leveraging forked and specialized networks-benchmarking scRNA-seq data in multi-omics-based prediction of cancer sensitivity","volume":"39","author":"Piochi","year":"2023","journal-title":"Bioinformatics"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"bbae184","DOI":"10.1093\/bib\/bbae184","article-title":"Prior knowledge-guided multilevel graph neural network for tumor risk prediction and interpretation via multi-omics data integration","volume":"25","author":"Yan","year":"2024","journal-title":"Brief. Bioinform."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Lam, R.C.T., Johnson, D., Lam, G., Li, M.L.Y., Wong, J.W.L., Lam, W.K.J., Chan, K.C.A., and Ma, B. (2022). Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers\u2014Current evidence and future directions. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.970242"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"100960","DOI":"10.1016\/j.jpha.2024.03.001","article-title":"Mechanisms and therapeutic targets of ferroptosis: Implications for nanomedicine design","volume":"14","author":"Zhang","year":"2024","journal-title":"J. Pharm. Anal."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Tang, Z., Huang, Z., Huang, Y., Chen, Y., Huang, M., Liu, H., Ye, Q.A., Zhao, J., and Jia, B. (2021). Ferroptosis: The Silver Lining of Cancer Therapy. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.765859"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/jcmm.13008","article-title":"Ferroptosis, a new form of cell death, and its relationships with tumourous diseases","volume":"21","author":"Yu","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Capelletti, M.M., Manceau, H., Puy, H., and Peoc\u2019h, K. (2020). Ferroptosis in Liver Diseases: An Overview. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144908"},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"Wang, Y., Liu, T., Li, X., Sheng, H., Ma, X., and Hao, L. (2021). Ferroptosis-Inducing Nanomedicine for Cancer Therapy. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.735965"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41419-021-04490-1","article-title":"Double-edge sword roles of iron in driving energy production versus instigating ferroptosis","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cai2.7","article-title":"Crosstalk between ferroptosis and stress-Implications in cancer therapeutic responses","volume":"1","author":"Zhang","year":"2022","journal-title":"Cancer Innov."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP Cyclohydrolase 1\/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Nie, Z., Chen, M., Gao, Y., Huang, D., Cao, H., Peng, Y., Guo, N., Wang, F., and Zhang, S. (2022). Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.879317"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"351959","DOI":"10.1155\/2014\/351959","article-title":"Tumor microenvironment: A new treatment target for cancer","volume":"2014","author":"Tsai","year":"2014","journal-title":"ISRN Biochem."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10147-019-01520-z","article-title":"Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology","volume":"25","author":"Saito","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41598-023-29065-2","article-title":"Tumor organoid biobank-new platform for medical research","volume":"13","author":"Xie","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/TCRM.S4749","article-title":"Challenging issues in molecular-targeted therapy","volume":"5","author":"Ezziane","year":"2009","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14789450.2019.1559062","article-title":"Cancer biomarker discovery and translation: Proteomics and beyond","volume":"16","author":"Hristova","year":"2019","journal-title":"Expert Rev. Proteom."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/2\/252\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:06:00Z","timestamp":1770033960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/2\/252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":225,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ph19020252"],"URL":"https:\/\/doi.org\/10.3390\/ph19020252","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}